This Award Notice opportunity from Department Of Health And Human Services was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Four indefinite delivery/indefinite quantity contracts worth up to $49,999,999 each were awarded on May 4, 2026, under the Drug Manufacturing and Formulation Program, with an ordering period spanning ten years from May 4, 2026, to May 3, 2036. Each contract was issued simultaneously with a first task order effective immediately through July 3, 2026, for a firm-fixed price of $5,000 per awardee. The solicitation, numbered 75N95024R00077, was posted on May 5, 2026, under NAICS code 325412 for pharmaceutical and medicinal product manufacturing, with no set-aside provisions applied. The contracts were awarded by the National Institutes of Health, specifically the National Institute on Drug Abuse within the Department of Health and Human Services, based in Bethesda, Maryland, and the work is to be performed in Kansas City, Missouri. Primary point of contact is Rieka N. Plugge, with secondary contact Kelly Dempsey, both reachable through NIH email addresses.
General Info
Four IDIQ contracts worth nearly $50M each for drug manufacturing, 2026–2036, initial $5K task orders, NIH NIDA awarded.
PDF, High priority: read this first2 pages · specifications
HighAI Summary for Additional Technical Proposal Instructions: This document provides detailed technical proposal instructions for offerors, outlining specific requirements for Performance Activities (PA). It details requirements for a Kickoff Meeting (PA1), General Project Administration and Technical Support (PA2A), and API Scale Up, Manufacture, Formulation, and Analytical Methods Development (PA2B), including cGMP/GLP compliance and FDA submission support.
PDF
PDF, High priority: read this first54 pages · amendment
HighAI Summary for Amendment 00002 - RFP 75N95024R00077 (Drug Manufacturing and Formulation Program): Issued on July 5, 2024, Amendment #00002 for RFP 75N95024R00077 (Drug Manufacturing and Formulation Program) provides answers to offeror questions and modifies the RFP. It replaces Amendment #00001 in its entirety due to an upload error on sam.gov. Key clarifications include requirements for a detailed technical proposal for Sample Task Order #0001 and compliance with FAR Part 25.7 regarding foreign components.
XLSX
XLSX, High priority: read this first25 pages · specifications
HighAI Summary for Breakdown of Proposed Costs Template: A cost proposal template (updated 08/06/2014) used by the NIH to standardize the submission of proposed costs. It includes detailed instructions for calculating direct labor (hourly and percent of effort), fringe benefits, overhead, G&A, and other direct costs across seven periods.
PDF
PDF, High priority: read this first24 pages · sow
HighAI Summary for Drug Manufacturing and Formulation Program (DMFP) Statement of Work: Dated 06/07/2024, this Statement of Work (SOW) outlines the requirements for the National Institute of Neurological Disorders and Stroke (NINDS) to award multiple ID/IQ contracts for the Drug Manufacturing and Formulation Program (DMFP). The scope includes API scale-up and manufacture, formulation, dosage form manufacture, analytical method development, and stability testing in accordance with cGMP and GLP regulations to support the Blueprint Neurotherapeutics Network (BPN) in transitioning drug candidates to clinical stages.
PDF
PDF, High priority: read this firstspecifications
HighAI Summary for NIDA Supplemental Billing Instructions (Exhibit A): This document is Exhibit A to NIH(RC)-1, Rev. 3/2021, providing supplemental billing instructions for NIDA contractors. It specifies detailed invoicing requirements for direct labor, travel, materials/equipment, subcontract costs, honoraria reimbursements, and indirect cost adjustments, as well as notification requirements for fund overruns or unexpended balances.
PDF
PDF, High priority: read this first2 pages · submission-instructions
HighAI Summary for NIH Packaging and Delivery of Proposals (Attachment 1): Dated March 12, 2018, this document provides mandatory instructions for the packaging and delivery of proposals via the NIH electronic Contract Proposal Submission (eCPS) website. It specifies the requirement for separate PDF files for Technical and Business proposals, the necessity of an Excel spreadsheet for cost breakdowns, and the required file naming conventions to ensure compliance with FAR Clause 52.215-1.
PDF
PDF, High priority: read this first134 pages · rfp
HighAI Summary for RFP 75N95024R00077 - Drug Manufacturing and Formulation Program (DMFP): Issued June 7, 2024, by the National Institute of Neurological Disorders and Stroke (NINDS), this Request for Proposal (RFP) seeks proposals for the Drug Manufacturing and Formulation Program (DMFP). The government intends to award three to five IDIQ, task order type contracts with a 10-year performance period (Jan 2025 - Jan 2035) and a maximum value of $49,999,999. Proposals are due July 22, 2024, via the eCPS website.
PDF
PDF, High priority: read this first19 pages · task-order-award
HighAI Summary for Sample Task Order #0001 and Statement of Work: This document consists of a Task Order and Statement of Work (SOW) for the process development, chemical synthesis, and GMP scale-up manufacturing of a specific compound. It details technical requirements for API manufacturing (capsules and injectables), preformulation studies, and the production of a 200g demonstration batch. It includes specific reporting requirements, ICH stability study parameters, and deliverables necessary for regulatory filings such as IND-filing with the FDA.
PDF
PDF, High priority: read this firstamendment
HighAI Summary for Sol_75N95024R00077_Amd_0002: Amendment 00002 to RFP 75N95024R00077 for the Drug Manufacturing and Formulation Program (DMFP), issued July 5, 2024. The purpose is to provide answers to offeror questions and make changes to the RFP. This amendment replaces Amendment 000001 in its entirety. It includes a Q&A section regarding technical proposal requirements, service scope, and foreign company restrictions.
PDF
PDF, High priority: read this first6 pages · amendment
HighAI Summary for Solicitation 75N95024R00077 Amendment 0003: Amendment #00003 dated 07/15/2024 for RFP No. 75N95024R00077 issued by the National Institute on Drug Abuse (NIDA). The purpose of this amendment is to provide answers to additional questions received after Amendment #00002 and to make further revisions to the RFP. The period of performance is listed as 01/15/2025 to 01/14/2035.
PDF
PDF, High priority: read this first1 page · bid-schedule
HighAI Summary for Technical Proposal Cost Information/Summary of Labor and Direct Costs: A template for the Technical Proposal Cost Information/Summary of Labor and Direct Costs (dated 1/2011). It requires the breakdown of direct labor hours by category over seven years, as well as costs for materials, travel, and other direct expenses, specifically excluding indirect costs, fees, and individual salaries.
PDF
PDF, High priority: read this first11 pages · wage-determination
HighAI Summary for Wage Determination No. 2015-4269 (Maryland): U.S. Department of Labor Wage Determination No. 2015-4269, Revision 24, dated 12/26/2023. This document specifies the minimum wage rates for various occupations in Frederick and Montgomery counties, Maryland, under the Service Contract Act, including guidelines for Executive Orders 14026 and 13658.
PDF
PDF, Low priority1 page · other
LowAI Summary for A12_Disclosure-Loobying_Activities.pdf: Unreadable document.
PDF
PDF, Low priority1 page · other
LowAI Summary for A8 Proposal Summary Data Record: The document appears to be a corrupted or improperly encoded data record containing fragmented text and non-standard characters. While it references 'Proposal Summary' and 'Data Record' in the filename, the content is largely unreadable and consists of scrambled alphanumeric strings.
LowAI Summary for Annual Representations and Certifications (May 2024): A standard federal procurement document (updated per FAC 2024-05) requiring offerors to provide annual representations and certifications. It specifies NAICS code 325412 and outlines various FAR provisions regarding small business size standards, SAM registration, and legal certifications.
PDF
PDF, Low priority2 pages · nda
LowAI Summary for Contractor Non-Disclosure Agreement (NDA): A standard Non-Disclosure Agreement (NDA) form for contractors and subcontractors working with the National Institutes of Health (NIH). The document outlines the commitment to protect non-public information, notification requirements for unauthorized disclosures, and the legal penalties associated with improper disclosure under U.S. law.
PDF
PDF, Low priority1 page · special-notice
LowAI Summary for Determination of Exceptional Circumstances Acknowledgment Form: An acknowledgment form for the NINDS acquisition requiring the offeror to certify and agree to the terms of HHSAR Clauses 352.227-11 (Patent Rights-Exceptional Circumstances) and 352.227-14 (Rights in Data-Exceptional Circumstances).
PDF
PDF, Low priorityother
LowAI Summary for Employee Separation Checklist: A standardized checklist for contractors to manage the offboarding of staff members, distinguishing between friendly and unfriendly separations. It outlines required actions for removing system access, recovering government property, and notifying NIH security officials.
PDF
PDF, Low priority7 pages · supporting-documents
LowAI Summary for NIH(RC)-1 Invoice/Financing Request Instructions: Instructions for contractors on how to prepare and submit payment requests for NIH cost-reimbursement type contracts. The document details required formats, submission frequency, identification requirements (TIN, DUNS), and the specific data elements needed for interim, completion, and final invoices.
PDF
PDF, Low priority1 page · other
LowAI Summary for Offeror's Points of Contact Form: A standard form requiring the offeror to provide contact information for the Business Representative and Proposed Principal Investigator to be submitted with the business proposal.
PDF
PDF, Low priority1 page · intent-to-bid
LowAI Summary for Proposal Intent Response Form: A form used by potential bidders to notify the Contracting Officer whether they intend to submit a proposal in response to a Request for Proposal (RFP). It collects contact information and reasons for non-participation to assist in evaluation planning.
PDF
PDF, Low priority1 page · supporting-document
LowAI Summary for Summary of Related Activities: A form requiring offerors to disclose the current commitments and proposed levels of effort for key professional personnel, including active federal/commercial contracts and outstanding proposals.
Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida
Get AI-powered intelligence on the opportunities still open
Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.